Invitae (NYSE:NVTA) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Invitae (NYSE:NVTA) in a report issued on Monday morning. The brokerage issued a hold rating on the medical research company’s stock.

Invitae Price Performance

NVTA opened at $0.00 on Monday. The business’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.36. Invitae has a 1 year low of $0.02 and a 1 year high of $0.02. The company has a market capitalization of $907,834.00, a price-to-earnings ratio of 0.00 and a beta of 1.59.

Institutional Trading of Invitae

Several hedge funds and other institutional investors have recently modified their holdings of NVTA. Veritable L.P. bought a new position in shares of Invitae in the 1st quarter valued at about $25,000. SG Americas Securities LLC bought a new position in shares of Invitae in the 3rd quarter valued at about $29,000. Captrust Financial Advisors grew its holdings in shares of Invitae by 501.1% in the 2nd quarter. Captrust Financial Advisors now owns 14,396 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 12,001 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Invitae by 113.2% in the 1st quarter. Tower Research Capital LLC TRC now owns 26,626 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 14,137 shares in the last quarter. Finally, Engineers Gate Manager LP bought a new position in shares of Invitae in the 4th quarter valued at about $35,000. Institutional investors and hedge funds own 61.28% of the company’s stock.

Invitae Company Profile

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services.